ESMO 2019: First-line avelumab plus axitinib in sarcomatoid kidney cancer – results from JAVELIN Renal 101
Results from the JAVELIN Renal 101 study to evaluate avelumab [...]
Results from the JAVELIN Renal 101 study to evaluate avelumab [...]
Results from a post-hoc analysis of JAVELIN-Renal 101 in patients [...]
Results from the TRAXAR clinical trial to assess TRC105 plus [...]
Results from the JAVELIN-Renal 101 clinical trial to assess avelumab [...]
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines [...]
Based on the findings from the pivotal phase 3 KEYNOTE-426 [...]
The Committee for Medicinal Products for Human Use (CHMP) of [...]
It has just been announced that the avelumab plus axitinib [...]
Results from the biomarker analysis from the JAVALIN Renal 101 [...]
A phase 2 study published in the British Journal of [...]